Rocket Lab's Reliability Pays Off with Major Funding and Key Contracts

Rocket Lab raises $1.1B, signs new iQPS launches, and acquires Mynaric to support major U.S. contracts and Neutron rocket development, targeting $880M revenue in 2026.

Rocket Lab has demonstrated that consistent performance is the ultimate currency in the competitive launch sector. This principle was underscored this week as the company announced a significant new launch contract with Japanese satellite operator iQPS, adding three Electron missions from New Zealand starting in 2028. This expansion brings the total number of booked missions for iQPS to 15, a testament to a partnership built on a flawless track record of seven successful launches since 2023.

The company's operational momentum is now backed by an unprecedented financial foundation. Rocket Lab recently concluded one of the largest capital raises in its history, amassing a war chest of up to $1.1 billion. The funding originated from an at-the-market program that ended on April 8, 2026, which generated approximately $474 million from the sale of 6.7 million shares. It was supplemented by collared-forward transactions providing an additional $474 million to $642 million, due in April 2028.

A substantial portion of this capital is earmarked for a transformative strategic move: the acquisition of German laser communications specialist Mynaric. With approval from the German Federal Ministry for Economic Affairs secured, the deal is expected to close in April 2026. This acquisition is not merely a geographic expansion into Europe, with Mynaric remaining based in Munich, but a critical enabler for a major U.S. government contract. Mynaric's optical communication terminals are essential for Rocket Lab to fulfill a $1.3 billion primary contract with the U.S. Space Development Agency to build 36 satellites.

Financially, the company is on a steep growth trajectory. Revenue for 2025 reached $602 million, with management targeting nearly $880 million for 2026. The firm's backlog is robust, standing at over $2 billion. This figure is bolstered by several major awards, including the $816 million Space Development Agency contract and a separate $190 million contract for hypersonic testing. Commercial activity remains feverish, with Rocket Lab selling 28 launches in the first quarter of 2026 alone—nearly matching its total for the entire previous year.

Looking to the medium term, the next major growth driver is clearly in sight. The Neutron medium-lift rocket, a 43-meter-tall, partially reusable vehicle, is in its final assembly phase. Key components like the "Hungry Hippo" payload fairing are complete, and the inaugural launch is scheduled for late 2026 or early 2027. Analysts, including Clear Street's Gregory Pendy, view Neutron as a central revenue catalyst due to its ability to address a significantly larger market than the existing Electron rocket.

Wall Street maintains a favorable outlook despite the stock's noted volatility, which has seen it trade between $16.73 and $99.58 over the past twelve months. The average analyst price target implies an upside of roughly 25% from current levels, based on a consensus of ten buy and five hold ratings over the last three months. Roth MKM analyst Sujeeva De Silva recently reaffirmed a buy rating with a $90 price target. Furthermore, the consensus EPS estimate for 2026 has been revised upward by 44% over the past 60 days.

While a significant portion of Rocket Lab's backlog is tied to U.S. government programs, introducing a dependency on federal funding cycles, the company enters the second quarter of 2026 from a position of unprecedented strength. With a fully funded balance sheet, a key European acquisition imminent, and its next-generation rocket on the launch pad, Rocket Lab has more strategic flexibility than at any point in its history.